$ACET News

Are Medical Stocks Lagging Adicet Bio (ACET) This Year?

Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade

Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference

Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

Adicet Bio Q1 EPS $(1.88) Beats $(3.21) Estimate

Adicet Bio (ACET) Upgraded to Buy: Here's Why

HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $100

Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress

Adicet Bio Files Prospectus To Offer Up To $250M In Common Stock

Adicet Bio Q4 EPS $(2.94) Beats $(3.10) Estimate

Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $50

Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones

Adicet Bio Extends Cash To 2027 As Enrollment Doubles For Lead Autoimmune Drug

ACET stock has given up its prior loss. Adicet Bio shares were trading lower after the company announced a 1-for-16 reverse stock split.

Adicet Bio Announces Reverse Stock Split

What's Going On With Adicet Bio Stock Today?

Adicet Bio shares are trading lower after the company announced a 1-for-16 reverse stock split.

Adicet Bio Announces 1-for-16 Reverse Stock Split